Harbor is now
Start for $99No results? No chargeSame-day approvalNo price increases — everBuy now, pay later
Harbor
Questions? Text us+1 (332) 205-9094

10 Glutathione Benefits & What the Evidence Actually Supports

Glutathione benefits get big claims online. Here are ten, each graded by the human evidence behind it and the route that was actually tested, so you can see where the research is solid and where it stops.

Clinically reviewed
Medically reviewed by Harbor Health TeamMedical Content Team7 min read
Take Quiz Read

The top three

Human trials, route named
Our pick

01  Antioxidant protection for your cells

Grade A for stores, mixed for outcomes

30-35%higher blood glutathione at 6 months, oral

02  Liver health support

Promising, not proven

29patients finished the largest pilot

03  Skin brightness & even tone

Modest, site-specific results

2 of 6skin sites lighter than placebo

Most results are oral. Almost every positive human result here comes from oral or inhaled glutathione in small groups. No trial has tested injections for skin, liver, aging or energy.

Glutathione benefits at a glance

Glutathione is a tripeptide, three amino acids (glutamate, cysteine and glycine) that your cells build every day. It neutralizes peroxides and helps the liver package drugs and toxins for removal. That much is textbook biology. What extra glutathione does is less settled.

People ask what are the benefits of glutathione as a supplement or injection. Here is the honest answer: the role in the body is clear, but human trials of adding more are thin. The benefits of glutathione below are graded A for randomized human trials with a measurable result, B for small or uncontrolled human studies, and C for animal, lab or null results. For how a program works, see what is glutathione therapy.

Glutathione benefits ranked by evidence

Each of these glutathione benefits is graded with the route its studies used. Route matters: a 1992 single-dose study found that 3 g taken by mouth did not raise blood glutathione, while longer oral use did in a later trial.

The same grades apply to glutathione peptide benefits. Many glutathione health benefits are claimed for foods and habits that help your body make its own. Harbor covers those in how to increase glutathione.

01

Antioxidant protection for your cells

Mixed outcomes, grade A for stores

30-35%higher blood glutathione at 6 months, oral

Glutathione is one of the body's main antioxidants. Evidence that more lowers oxidative stress in healthy people is mixed, but one long trial raised the body's stores.

Where it wins

  • 1,000 mg a day by mouth raised blood glutathione 30-35% in a 54-person, 6-month RCT
  • The oxidized-to-reduced glutathione ratio fell, signaling less oxidative stress
  • A liposomal pilot raised whole-blood levels by up to 40% in two weeks

What it costs you

  • A 4-week trial at 500 mg twice daily found no change
  • Levels fell back to baseline within a month of stopping
  • The liposomal pilot had 12 people, no placebo and maker funding

Grade A for stores, mixed for outcomes

02

Liver health support

Small uncontrolled studies, grade B

29patients finished the largest pilot

Liver enzymes fell on oral glutathione in early, uncontrolled studies of fatty liver disease. No placebo-controlled trial has confirmed a liver benefit.

Where it wins

  • ALT, a liver enzyme, fell after 4 months of 300 mg a day in a 34-person pilot
  • Triglycerides and ferritin also dropped
  • A 15-person study saw ALT fall in NASH

What it costs you

  • No placebo group in either study
  • The larger pilot was partly funded by a glutathione maker
  • Authors call for large trials first

Promising, not proven

03

Skin brightness & even tone

Small oral trials, grade A

2 of 6skin sites lighter than placebo

Small randomized trials of oral glutathione found modest lightening at some skin sites. The glutathione benefits skin studies point to are real but narrow, and come from pills, not injections.

Where it wins

  • 500 mg a day for 4 weeks lightened 2 of 6 measured sites vs placebo in 60 students
  • A 12-week trial in 60 women saw wrinkle reductions at some sites
  • Oral doses were well tolerated

What it costs you

  • Overall melanin changes in the women's trial were not significant
  • One trial was funded by a glutathione maker
  • Reviews find no good evidence for IV glutathione on skin

Modest, site-specific results

04

Insulin sensitivity & blood sugar

One open-label trial, grade B

55+age group where HbA1c changed, post hoc

In an open-label trial of 250 people with type 2 diabetes, 500 mg of oral glutathione a day helped hold HbA1c steady, with a significant change only in those over 55.

Where it wins

  • Blood glutathione rose and an oxidative DNA marker fell within 3 months
  • HbA1c and fasting insulin improved in people over 55

What it costs you

  • No placebo and no blinding
  • The over-55 finding was a post hoc analysis
  • Glycine and cysteine studies tested precursors, not glutathione

A hint in diabetes, not a treatment

05

Immune system support

Lab markers only, grade B

2xnatural killer cell activity at 3 months

Immune cell activity rose on oral glutathione in two small studies, but neither counted colds or infections.

Where it wins

  • Natural killer cell activity more than doubled on 1,000 mg a day in the 6-month RCT
  • The liposomal pilot saw a rise of up to 400% in two weeks

What it costs you

  • Secondary outcomes, measured in subsets
  • No study tracked illness

Lab signals, no illness data

06

Exercise recovery

One tiny crossover, grade B

8men in the only glutathione-alone trial

Eight men took 1 g of oral glutathione a day for two weeks before a cycling session. That is the whole human evidence for glutathione alone.

Where it wins

  • Lactate after exercise was lower than on placebo
  • Self-reported fatigue fell

What it costs you

  • Eight participants
  • Supported by a glutathione maker
  • Combination products cannot isolate glutathione's effect

Too small to rely on

07

Healthy aging

Precursor trials, not glutathione

24older adults in the GlyNAC trial

The best aging data used glycine and N-acetylcysteine, the building blocks your body makes glutathione from, not glutathione itself.

Where it wins

  • In a 16-week RCT of 24 older adults, GlyNAC corrected low glutathione and improved strength and gait speed
  • An open-label pilot saw benefits fade after stopping

What it costs you

  • Precursors, not glutathione
  • Small samples
  • No trial of glutathione injections for aging

Building blocks, not the molecule

08

Lung & airway health

Inhaled, cystic fibrosis only, grade A

3.5%FEV1 gain at 3 months, not 6

Inhaled glutathione has been tested only in cystic fibrosis, where a Cochrane review found a small lung-function gain at three months that was gone by six.

Where it wins

  • Two studies, 258 people: FEV1 up 3.5% at 3 months
  • Moderate-quality evidence, per Cochrane

What it costs you

  • The largest RCT missed its primary endpoint
  • Inhaled use in one disease says nothing about healthy lungs
  • A different route from injections

Narrow, disease-specific evidence

09

Brain health research

Trials did not beat placebo, grade C

0Parkinson's trials that beat placebo

Brain glutathione drops early in Parkinson's disease, so researchers test it there. IV and nasal trials have not beaten placebo.

Where it wins

  • Nasal glutathione raised brain glutathione for at least an hour in 15 patients
  • Nasal doses were well tolerated in a safety study

What it costs you

  • IV glutathione, 3 times a week for 4 weeks, matched placebo in 21 patients
  • A 45-patient nasal trial found no group beat placebo

Active research, no benefit shown

10

Heart & blood vessel health

Hospital IV studies, grade B

196 mpain-free walking vs 143 m on saline

Short IV courses in people with artery disease or a recent heart attack showed vascular signals. Nothing shows routine glutathione protects a healthy heart.

Where it wins

  • 5 days of IV glutathione improved pain-free walking in 40 patients with peripheral artery disease
  • IV glutathione around angioplasty lowered inflammation markers in 100 heart attack patients

What it costs you

  • Hospital patients with existing disease
  • Short courses, short follow-up

Clinical signals, not prevention

How to choose a glutathione form

The route changes what the evidence can tell you.

  • Oral capsules: the only form with a 6-month randomized trial showing higher body stores. Most glutathione supplement benefits here come from oral studies.
  • Liposomal: liposomal glutathione benefits rest on one 12-person pilot with fast blood-level rises and no placebo.
  • IV: glutathione IV benefits have been tested in hospital patients and Parkinson’s, not for wellness, skin or energy.
  • Injection: glutathione injection benefits have not been tested in a published wellness trial, although injecting bypasses the gut.

Quality matters as much as route. In August 2026 the FDA reported adverse events in at least 30 patients after IV glutathione made from dietary-supplement-grade ingredients, which are not appropriate for injectables. Glutathione is still under FDA evaluation for compounding and is not an FDA-approved drug.

Harbor glutathione injections start at $89 a month. They are compounded by a licensed U.S. pharmacy, are not FDA-approved, and are prescribed only after a clinician reviews your health history. The program supports your levels rather than promising a specific result.

When to get care now

Fever, chills, dizziness or signs of shock after an injection, or trouble breathing and swelling of the face or throat, need emergency care. For injection-site redness or any other question, message your Harbor clinician.

Frequently asked questions

There are no proven glutathione benefits for women specifically. The skin trials enrolled mostly or only women, one found effects only in those over 40, and no human glutathione trials cover PCOS or pregnancy, so safety there is not established.

Not on current evidence. No published trial compares injections with oral glutathione on any outcome, and the strongest positive trial used capsules. If you also take NAD+, see taking NAD+ & glutathione together.

Blood levels rose within one to two weeks on liposomal glutathione and by 3 to 6 months on capsules, but rising levels are not the same as felt glutathione benefits, which most trials did not measure.

Sources

  1. Glutathione, PubChem, NIH.
  2. Witschi A et al. The systemic availability of oral glutathione. Eur J Clin Pharmacol. 1992.
  3. Richie JP et al. Randomized trial of oral glutathione on body stores. Eur J Nutr. 2015.
  4. Allen J, Bradley RD. Oral glutathione and oxidative stress biomarkers. J Altern Complement Med. 2011.
  5. Sinha R et al. Oral liposomal glutathione and body stores. Eur J Clin Nutr. 2018.
  6. Honda Y et al. Oral glutathione in nonalcoholic fatty liver disease. BMC Gastroenterol. 2017.
  7. Irie M et al. Oral glutathione in fatty liver and NASH. Euroasian J Hepatogastroenterol. 2016.
  8. Arjinpathana N, Asawanonda P. Oral glutathione and skin lightening. J Dermatolog Treat. 2012.
  9. Weschawalit S et al. Glutathione and skin properties in women. Clin Cosmet Investig Dermatol. 2017.
  10. Sonthalia S et al. Glutathione for skin lightening: a review. 2018.
  11. Davids LM et al. Glutathione and skin lightening. S Afr Med J. 2016.
  12. Kalamkar S et al. Oral glutathione in type 2 diabetes. Antioxidants. 2022.
  13. Sekhar RV et al. Glutathione precursors in type 2 diabetes. Diabetes Care. 2011.
  14. Aoi W et al. Glutathione and exercise fatigue. J Int Soc Sports Nutr. 2015.
  15. Kumar P et al. GlyNAC in older adults, randomized trial. J Gerontol A. 2023.
  16. Kumar P et al. GlyNAC pilot in older adults. Clin Transl Med. 2021.
  17. Griese M et al. Inhaled glutathione in cystic fibrosis. Am J Respir Crit Care Med. 2013.
  18. Ciofu O et al. Antioxidant supplementation for cystic fibrosis. Cochrane Review. 2019.
  19. Hauser RA et al. IV glutathione in Parkinson's disease. Mov Disord. 2009.
  20. Mischley LK et al. Intranasal glutathione and brain levels. 2016.
  21. Mischley LK et al. Phase IIb intranasal glutathione in Parkinson's disease. 2017.
  22. Arosio E et al. IV glutathione in peripheral artery disease. Mayo Clin Proc. 2002.
  23. Tanzilli G et al. Glutathione infusion in STEMI. J Am Heart Assoc. 2021.
  24. FDA reminds compounders not to use dietary supplement grade glutathione in injectables, 2026.
  25. FDA 503A bulk drug substance categories, updated May 14, 2026.

Keep reading

All 163 articles →
  • Longevity

    6 Longevity Peptides & What Each One Is For

    Most longevity peptides are sold on promise rather than proof. Here are six of the most discussed, what each one is actually approved or studied for, how much human evidence stands behind it, and where the FDA has raised concerns.

    By Harbor Health Team